Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 22 (MTND2P22) is a non-coding pseudogene in the human genome, named for its similarity to the mitochondrial gene MT-ND2, which encodes a core subunit of NADH:ubiquinone oxidoreductase (complex I) in the mitochondrial electron transport chain. MTND2P22 does not produce a functional protein product and is classified as a pseudogene without an assigned biological or clinical role. There is no evidence that MTND2P22 directly participates in disease processes or is a target for any drugs[4]. Key distinctions: The functional MT-ND2 gene encodes a protein critical for mitochondrial electron transport and has clinical relevance in several mitochondrial diseases[1][5]. MTND2P22 is NOT the functional MT-ND2 gene; it is a nuclear-encoded pseudogene and thus not a therapeutic target[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 22 (MTND2P22).